COHEN & STEERS, INC.
No SEC Form 4 filings for $CNS in the last 30 days.
See all $CNS insider activity →Cohen & Steers (NYSE: CNS) plans to release Q3 2026 results on October 15, 2026, followed by a conference call on October 16, 2026. CEO Joseph Harvey, CFO Amit Muni, and President Jon Cheigh will discuss earnings, operating results, and outlook. Details and access information are available on the company's website.
Cohen & Steers (CNS) reported FY2025 revenue of $571.5M (up from $514.2M in FY2024) and LTM revenue of $604.7M (up 6.9% YoY). AUM was $102.5B in July, with $528M in net inflows in August despite market depreciation. Q2 net inflows were $1.3B, adjusted EPS $0.85, and operating margin 36.3%. CEO Joseph Harvey highlighted real estate market trends as a growth driver. The stock trades at 18.45x forward earnings.
StepStone Group (STEP) reported Q2 revenue of $300.6M, up 26.6% YoY but missing estimates. Cohen & Steers (CNS) reported $152.7M revenue, up 12.2% YoY, beating estimates. Voya Financial (VOYA) reported $1.88B revenue, flat YoY, missing EPS estimates. All stocks traded mixed post-results.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CNS (COHEN & STEERS, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent CNS coverage spans earnings, financial news and technology.
The announcement provides the earnings release schedule but no financial numbers, so immediate price impact is limited.
Modest downside pressure as market depreciation outweighs inflows, but strong cash flow and margin may limit decline.
Revenue beat supports a modest upside, but flat EPS limits upside.
Index methodology updates can shift benchmark constituents and weights, potentially affecting flows into CNS-linked products and real-estate equity exposure.
New ETF launch can drive incremental AUM and fee revenue, but near-term impact on CNS stock is likely limited without disclosed flows or performance.
AlphAI scores every news story that mentions CNS with an AI model for sentiment and relevance, and aggregates insider trades from COHEN & STEERS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cohen & Steers (NYSE: CNS) plans to release Q3 2026 results on October 15, 2026, followed by a conference call on October 16, 2026. CEO Joseph Harvey, CFO Amit Muni, and President Jon Cheigh will discuss earnings, operating results, and outlook. Details and access information are available on the company's website.
1 min readCohen & Steers (CNS) reported FY2025 revenue of $571.5M (up from $514.2M in FY2024) and LTM revenue of $604.7M (up 6.9% YoY). AUM was $102.5B in July, with $528M in net inflows in August despite market depreciation. Q2 net inflows were $1.3B, adjusted EPS $0.85, and operating margin 36.3%. CEO Joseph Harvey highlighted real estate market trends as a growth driver. The stock trades at 18.45x forward earnings.
2 min readStepStone Group (STEP) reported Q2 revenue of $300.6M, up 26.6% YoY but missing estimates. Cohen & Steers (CNS) reported $152.7M revenue, up 12.2% YoY, beating estimates. Voya Financial (VOYA) reported $1.88B revenue, flat YoY, missing EPS estimates. All stocks traded mixed post-results.
2 min readCohen & Steers (NYSE: CNS) said it will make pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective Aug. 21, 2026. The indexes are free-float adjusted, modified market-cap weighted total return measures quoted by CME, with S&P calculating weights.
2 min readCohen & Steers (NYSE: CNS) launched the Cohen & Steers Real Assets Active ETF (CSRA), which began trading on NYSE Arca on Aug. 12, 2026. The actively managed ETF targets diversified exposure across real estate, infrastructure, natural resources and commodities, according to the firm. The company also lists several other active ETFs in its lineup.
2 min readAlliance News says London stocks may open marginally higher as investors watch Strait of Hormuz talks and corporate earnings. Iran and Oman agreed a route and are finalizing joint management, but reopening depends on the US ending Iran port naval blockade. Company updates include WNX selling “Pain Away” to Mentholatum, Corero (CNS) revenue up 42% to $15.5m, PRE receiving $15m of a $165m investment, and TEK reporting H1 net assets $201.7m and profit after tax $144.8m.
7 min readCohen & Steers reported Q2 2026 revenue of $152.7M, up from $136.1M, and net income attributable to common stockholders of $49.3M, up from $36.8M. Diluted EPS rose to $0.95 from $0.72. The company cited higher advisory fees and AUM appreciation, with open-end AUM up 14% to $49.0B.
1 min readCohen & Steers reported Q2 cash and U.S. Treasuries of $219 million and about $136 million in liquid seed investments. Net inflows were $1.3 billion, the highest in four and a half years, driven mainly by open-end funds. U.S. real estate led with $833 million inflows. AUM outperformance was cited across 1-, 3- and 5-year periods, with mixed one-year results.
7 min readCohen & Steers (NYSE: CNS) reported Q2 CY2026 revenue of $152.7 million, up 12.2% year on year, exceeding Wall Street estimates by 1.1%. Non-GAAP earnings were $0.85 per share, in line with analysts’ consensus. After the results, shares fell 1.3% to $79.88, according to the article.
4 min readCohen & Steers, Inc. (NYSE: CNS) reported second-quarter 2026 results for the quarter ended June 30, 2026. The company said an earnings release and presentation are available on its investor relations site and will be discussed on a July 17, 2026 conference call led by CEO Joseph Harvey, CFO Amit Muni, and President Jon Cheigh.
2 min read
